---
schema_version: "secwatch.filing_event.v1"
accession: "0000920148-26-000162"
form_type: "8-K"
ticker: "LH"
cik: "0000920148"
company_name: "LABCORP HOLDINGS INC."
filed_at: "2026-07-30T10:53:18+00:00"
generated_at: "2026-07-30T10:55:06.557382+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Labcorp Q2 revenue up 5.8% to $3.73B, adjusted EPS $4.99 beats; raises FY guidance

## Summary
- Q2 diluted EPS $3.64 vs $2.84 (+28.5%); adjusted EPS $4.99 vs $4.35 (+14.9%), beating prior guidance.
- Revenue $3.73B, up 5.8% YoY; Diagnostics Labs +5.5%, Biopharma +6.5%.
- Raised FY 2026 adjusted EPS guidance to $18.10-$18.55 (up $0.30 at midpoint); revenue growth 5.4%-6.3%.
- Board approved $1.0B increase in share repurchase authorization, total remaining $1.4B.
- Completed acquisitions of Parkview Health outreach services and Tribal Diagnostics; quarterly dividend $0.72.

## SEC filing metadata
- accession: 0000920148-26-000162
- form_type: 8-K
- ticker: LH
- cik: 0000920148
- company_name: LABCORP HOLDINGS INC.
- filed_at: 2026-07-30T10:53:18+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/920148/000092014826000162/0000920148-26-000162-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/920148/000092014826000162/lh-20260730.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000920148-26-000162
- JSON: https://secwatch.observer/filing/0000920148-26-000162.json
- Plain text: https://secwatch.observer/filing/0000920148-26-000162.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.